Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Linas Wilkialis"'
Autor:
Linas Wilkialis, Nelson B. Rodrigues, Danielle S. Cha, Ashley Siegel, Amna Majeed, Leanna M. W. Lui, Jocelyn K. Tamura, Barjot Gill, Kayla Teopiz, Roger S. McIntyre
Publikováno v:
Brain Sciences, Vol 11, Iss 12, p 1620 (2021)
The COVID-19 pandemic has resulted in a predominantly global quarantine response that has been associated with social isolation, loneliness, and anxiety. The foregoing experiences have been amply documented to have profound impacts on health, morbidi
Externí odkaz:
https://doaj.org/article/d198c5ad64b548a79718dcf889f383e1
Autor:
Leanna M.W. Lui, Joshua D. Rosenblat, Danica Nogo, Linas Wilkialis, Roger S. McIntyre, Flora Nasri
Publikováno v:
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 33(3)
Background Inflammation, motivational anhedonia, and neuropsychiatric disorders are associated with significant functional impairment and are a major public health concern. The objective of this systematic review is to examine the relationship betwee
Autor:
Nelson B. Rodrigues, Leanna M.W. Lui, Rodrigo B. Mansur, Flora Nasri, Joshua D. Rosenblat, Roger S. McIntyre, Yena Lee, Linas Wilkialis, Orly Lipsitz, Ashley Siegel, Jocelyn K. Tamura, Amna Majeed, Hartej Gill
Publikováno v:
Psychiatry Research. 298:113800
Loneliness is a key determinant in the etiology of mental health disorders such as depression and has profound impacts on health, quality of life, and economic productivity. This narrative review uses extant neurobiology and evolutionary literature t
Autor:
Mehala Subramaniapillai, Hartej Gill, Lee Phan, Rodrigo B. Mansur, Houman Rashidian, Ashley Siegel, Simina Toma, Amna Majeed, Orly Lipsitz, Yena Lee, Leanna M.W. Lui, Flora Nasri, Benjamin I. Goldstein, Roger S. McIntyre, Roger C.M. Ho, Joshua D. Rosenblat, Nelson B. Rodrigues, Linas Wilkialis
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 104:110032
Numerous pharmacological treatments for mood disorders are currently available; however, rates of treatment resistance, relapse and recurrence remain high. Therefore, novel treatments acting outside of the conventionally targeted monoamine system are